ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Estalis 50/250, transdermale Pflaster - 24 Pflaster
54704097 Sandoz Pharmaceuticals AG
Estalis 50/250, transdermale Pflaster17.08.1999
  17.08.1999
Norethisterone and Estrogen (G03FA01)07.03.2005
WHO-DDD 
07.08.60.24 Pflaster
07.08.60. 
B  
Yes 
IPCI
32.44No
    
10 %53.70
  
7680547040979Synthetika
2190766● 
Composition
estradiolum 0.496 mg ut estradiolum hemihydricum 0.512 mg, norethisteroni acetas 4.8 mg, silicone adhesive, acrylic adhesive, povidonum K 30, acidum oleicum, dipropylenglycolum, Trägermaterial: ad praeparationem pro 16 cm², cum liberatione 50 µg et 250 µg/24 h.
Packungsbestandteile
Transdermal patch 
 
Active AgentDose
Estradiol 0.496 mg
Norethisterone Acetate4.8 mg
BAG: Active AgentDose
Estradiol 0.496 mg
Norethisterone Acetate4.8 mg
 
Inactive agentsDoseadditional_information
Acidum Oleicum  
Acrylic Adhesive  
Ad Praeparationem16 cmTrägermaterial
Cum Liberatione50µg et 250 µg / 24h 
Dipropylenglycol  
Povidonum K30  
Silicone Adhesive  
 
Source
Data was imported : 05.08.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home